Barbara Dunne

1.2k total citations
21 papers, 973 citations indexed

About

Barbara Dunne is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Barbara Dunne has authored 21 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Barbara Dunne's work include HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (3 papers). Barbara Dunne is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (3 papers). Barbara Dunne collaborates with scholars based in United Kingdom, Ireland and United States. Barbara Dunne's co-authors include John M.S. Bartlett, Sian Tovey, Caroline Witton, Tove Kirkegaard, Timothy G. Cooke, Liane M. McGlynn, Alison Lyon, Sarah E. Pinder, Ian O. Ellis and Andrew H.S. Lee and has published in prestigious journals such as Oncogene, Clinical Cancer Research and The Journal of Pathology.

In The Last Decade

Barbara Dunne

20 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Dunne United Kingdom 12 536 482 241 230 172 21 973
JS Reis‐Filho United Kingdom 10 412 0.8× 377 0.8× 150 0.6× 409 1.8× 147 0.9× 22 897
Yasuyo Ohi Japan 21 314 0.6× 635 1.3× 123 0.5× 474 2.1× 177 1.0× 60 1.2k
Alessandra Bersiga Italy 16 458 0.9× 641 1.3× 146 0.6× 658 2.9× 124 0.7× 31 1.2k
Susan Korenchuk United States 13 896 1.7× 348 0.7× 105 0.4× 204 0.9× 462 2.7× 18 1.4k
Philippe Haas Switzerland 8 588 1.1× 578 1.2× 100 0.4× 207 0.9× 230 1.3× 8 1.1k
P.M. Wencyk United Kingdom 12 371 0.7× 582 1.2× 107 0.4× 321 1.4× 81 0.5× 15 909
JFR Robertson United Kingdom 12 327 0.6× 435 0.9× 138 0.6× 333 1.4× 146 0.8× 13 830
Kimberly B. Koenig United States 12 245 0.5× 510 1.1× 160 0.7× 475 2.1× 203 1.2× 15 855
Atsushi Shimomura Japan 21 439 0.8× 513 1.1× 88 0.4× 595 2.6× 213 1.2× 48 1.1k
Anne‐Lise Børresen‐Dale Norway 15 822 1.5× 446 0.9× 210 0.9× 527 2.3× 123 0.7× 20 1.2k

Countries citing papers authored by Barbara Dunne

Since Specialization
Citations

This map shows the geographic impact of Barbara Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Dunne more than expected).

Fields of papers citing papers by Barbara Dunne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Dunne. The network helps show where Barbara Dunne may publish in the future.

Co-authorship network of co-authors of Barbara Dunne

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Dunne. A scholar is included among the top collaborators of Barbara Dunne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Dunne. Barbara Dunne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hennessy, Grace, et al.. (2023). Idiopathic granulomatous mastitis: a 5-year retrospective review of cases in a tertiary centre in Dublin, Ireland. Journal of Clinical Pathology. 77(12). jcp–2023. 2 indexed citations
2.
Pazderska, Agnieszka, et al.. (2021). Pheochromocytoma due to a novel SDHD variant presenting as unilateral visual loss. Endocrinology Diabetes and Metabolism Case Reports. 2021. 1 indexed citations
3.
Smyth, Paul, Fiona Quinn, Michael Jeffers, et al.. (2018). Potentially important miRNAs in enteropathy-associated T-cell lymphoma pathogenesis: A pilot study. Leukemia Research Reports. 10. 52–54. 2 indexed citations
4.
Cotter, Maura B., Aoife Maguire, Janice M. Walshe, et al.. (2017). Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(3). 321–328. 4 indexed citations
5.
Raheem, Omer, et al.. (2014). A clinico-pathological review of non-haematological metastases to the testes. Journal of Clinical Urology. 8(1). 30–32. 1 indexed citations
6.
Carroll, Paul, Simona Donatello, Elizabeth Connolly, et al.. (2011). Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue Samples. Biopreservation and Biobanking. 9(4). 389–398. 23 indexed citations
7.
Carroll, Paul, R. N. Clarke, Michael Farrell, et al.. (2011). Surgical management of an Irish cohort of BRCA-mutation carriers. The Breast. 20(5). 419–423. 4 indexed citations
8.
Blacam, Catherine de, Jennifer Gray, Esther M. John, et al.. (2008). Breast cancer outcomes following a national initiative in Ireland to restructure delivery of services for symptomatic disease. The Breast. 17(4). 412–417. 5 indexed citations
9.
Kirkegaard, Tove, Anjali Naresh, Vicky S. Sabine, et al.. (2008). Expression of Tumor Necrosis Factor α Converting Enzyme in Endocrine Cancers. American Journal of Clinical Pathology. 129(5). 735–743. 8 indexed citations
10.
Kirkegaard, Tove, Liane M. McGlynn, Fiona Campbell, et al.. (2007). Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor–Positive Tumors of Tamoxifen-Treated Breast Cancer Patients. Clinical Cancer Research. 13(5). 1405–1411. 86 indexed citations
11.
Tovey, Sian, Barbara Dunne, Caroline Witton, Timothy G. Cooke, & John M.S. Bartlett. (2006). HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4. Breast Cancer Research. 8(2). R19–R19. 29 indexed citations
12.
Kirkegaard, Tove, et al.. (2006). Bad expression predicts outcome in patients treated with tamoxifen. Breast Cancer Research and Treatment. 102(2). 173–179. 41 indexed citations
13.
Edwards, Joanne, et al.. (2006). The Role of HER1-HER4 and EGFRvIII in Hormone-Refractory Prostate Cancer. Clinical Cancer Research. 12(1). 123–130. 83 indexed citations
14.
Bartlett, John M.S., et al.. (2005). Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer. The Journal of Pathology. 205(4). 522–529. 50 indexed citations
15.
Kirkegaard, Tove, Caroline Witton, Liane M. McGlynn, et al.. (2005). AKT activation predicts outcome in breast cancer patients treated with tamoxifen. The Journal of Pathology. 207(2). 139–146. 224 indexed citations
16.
Tovey, Sian, Barbara Dunne, Caroline Witton, et al.. (2005). Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer?. Clinical Cancer Research. 11(13). 4835–4842. 122 indexed citations
17.
Dunne, Barbara, et al.. (2003). An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Human Pathology. 34(10). 1009–1015. 119 indexed citations
18.
Sullivan, Alexandra, Martin Yuille, Claire E. Repellin, et al.. (2002). Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene. 21(9). 1316–1324. 67 indexed citations
19.
Gasco, Milena, Alex Sullivan, Claire E. Repellin, et al.. (2002). Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene. 21(12). 1876–1881. 86 indexed citations
20.
Dunne, Barbara, et al.. (1998). MDR1 expression is associated with adverse survival in melanoma of the uveal tract. Human Pathology. 29(6). 594–598. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JS Reis‐Filho Breakdown of academic impact, for papers by Yasuyo Ohi Breakdown of academic impact, for papers by Alessandra Bersiga Breakdown of academic impact, for papers by Susan Korenchuk Breakdown of academic impact, for papers by Philippe Haas Breakdown of academic impact, for papers by P.M. Wencyk Breakdown of academic impact, for papers by JFR Robertson Breakdown of academic impact, for papers by Kimberly B. Koenig Breakdown of academic impact, for papers by Atsushi Shimomura Breakdown of academic impact, for papers by Anne‐Lise Børresen‐Dale
Rankless by CCL
2026